
KANABO GROUP PLC — Investor Relations & Filings
Kanabo Group PLC is a digital health company focused on the research, development, and commercialization of cannabis-derived products. The company distributes cannabis-derived formulations for medical patients and non-THC products for CBD consumers. Its research and development efforts create proprietary, patent-pending formulas for conditions such as sleep and central nervous system (CNS) disorders. A key component of its offering is the VapePod®, a medically certified vaporization device that enables precise, metered-dosing of cannabis extracts. The company also operates The GP Service, a telehealth platform providing digital health services, including video consultations and online prescriptions, which integrates primary care with its specialist medicine offerings.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| Disposal of Subsidiary: The GP Service Limited | 2025-12-11 | English | |
| Appointment of Joint Administrators | 2025-11-28 | English | |
| Amended group accounts made up to 2023-12-31 | 2025-07-21 | English | |
| Temporary suspension of listing | 2025-04-30 | English | |
| Business Update | 2025-04-04 | English | |
| Resignation of Director | 2025-03-24 | English |
Browse filings by year
10 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2025
8 filings
| |||||
| 9837660 | Disposal of Subsidiary: The GP Service Limited | 2025-12-11 | English | ||
| 8791667 | Appointment of Joint Administrators | 2025-11-28 | English | ||
| 46832305 | Amended group accounts made up to 2023-12-31 | 2025-07-21 | English | ||
| 11347559 | Temporary suspension of listing | 2025-04-30 | English | ||
| 11333746 | Business Update | 2025-04-04 | English | ||
| 11326787 | Resignation of Director | 2025-03-24 | English | ||
| 5587221 | Revenue Growth, Trading and Operational Update | 2025-03-04 | English | ||
| 5562359 | Directorate Change | 2025-01-06 | English | ||
|
2024
7 filings
| |||||
| 2508215 | The GP Service Wins Award | 2024-11-19 | English | ||
| 5535629 | Correction Director/PDMR Shareholding | 2024-10-31 | English | ||
| 2381653 | Director/PDMR Shareholding | 2024-10-29 | English | ||
| 2319038 | Half-year Report | 2024-09-30 | English | ||
| 2079889 | Director/PDMR Shareholding | 2024-08-28 | English | ||
| 46832306 | Group of companies' accounts made up to 2023-12-31 | 2024-07-11 | English | ||
| 2052874 | Result of AGM | 2024-06-27 | English | ||
Financials
We couldn't load the financials
No data available yet
We have extracted financials for KANABO GROUP PLC, but not for this combination of statement and period. Try a different combination.
Swipe the table to view all periods, or rotate your phone for a wider view.
| Line item | ! |
|---|---|
| Definition not yet available — coming soon. |
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Apontis Pharma AG
Develops and markets fixed-dose combination drugs (Single P…
|
APPH | DE | Manufacturing |
|
Appili Therapeutics Inc.
Biopharmaceutical company developing novel medicines for in…
|
APLI | CA | Manufacturing |
|
Applied BioCode
Develops and manufactures high-throughput multiplex molecul…
|
6598 | TW | Manufacturing |
|
Applied Therapeutics, Inc.
Clinical-stage biopharma developing novel drugs for rare me…
|
APLT | US | Manufacturing |
|
Aprogen Biologics Inc.
Develops and manufactures novel biologics and biosimilar an…
|
003060 | KR | Manufacturing |
|
Aprogen, Inc
Develops and manufactures biologic medicines, including bio…
|
007460 | KR | Manufacturing |
|
Aptabio Therapeutics Inc.
Develops drugs for intractable diseases by regulating oxida…
|
293780 | KR | Manufacturing |
|
Aptamer Sciences Inc
Clinical-stage company developing aptamer-based therapeutic…
|
291650 | KR | Manufacturing |
|
Aptorum Group Ltd
Clinical-stage biopharma developing therapeutics for oncolo…
|
APM | US | Manufacturing |
|
Aptus Pharma Limited
Develops and manufactures cardiovascular, metabolic, and ga…
|
544529 | IN | Manufacturing |
KANABO GROUP PLC via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/4978/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=4978 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=4978 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=4978 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 4978}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for KANABO GROUP PLC (id: 4978)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.